Canna Law Blog

MARCH 4, 2020

From 2015 to 2018, the number of clinics increased from 60 to 300; that number is undoubtedly higher today. And as long as the healthcare provider in charge judges the infusion therapy to be ethical and not violative of safety standards, they may prescribe it accordingly.

Therapy 104

Therapy Legalization Chronic Pain DEA 104

Sensi Seeds

NOVEMBER 28, 2018

Then, a blog post circulated online, notifying the industry that Spain’s food and safety authority, AECOSAN, had updated its legislation to prohibit the sale and distribution of products containing CBD being sold as food supplements. In August 2018, reports of shops being raided and CBD product confiscated began to circulate on Twitter.

CBD 71

CBD Seed-To-Sale Food Research and Development 71

Cannabis Law Report

APRIL 8, 2022

Later that year, Doblin sued the DEA for the first time. The FDA formally decided to open the door to psychedelic research in human participants, and later accepted MAPS’ Phase 1 MDMA safety and tolerance study protocol. submitted his first DEA application to manufacture marijuana for use in medical research.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

JANUARY 11, 2019

Accordingly, the Drug Enforcement Administration (DEA) no longer has any claim to interfere with the interstate commerce of hemp products, so as long as the THC level is at or below 0.3%. While the DEA is now officially out of the hemp regulation business, the U.S. The FDA’s position on CBD is unsettled and unsupported by law.

Hemp 49

Hemp CBD Law Seed-To-Sale 49

Cannabis Law Report

MAY 1, 2019

For a business which has decided to publish ads for cannabis businesses, there are a number of steps that would minimize the risk of receiving a call from a federal prosecutor or a visit from your local DEA agent. See Medicinal and Adult-Use Cannabis Regulation and Safety Act, Cal. 2551, 2560 (2015). FOOTNOTES. & Prof.

Legalization 45

Legalization Business Law Cannabis 45

Cannabis Law Report

SEPTEMBER 23, 2019

Therefore, the AAFP advocates for further research into the overall safety and health effects of recreational use, as well as the effects of those laws on patient and societal health. The AAFP supports requirements testing current marijuana and cannabinoid products for safety, dosing, and product consistency. In the Exam Room.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

SpeedWeed

MARCH 7, 2021

And then, as those western states matured a little bit and then some events started happening for exhibits and the like, we sent a couple of people to scope it out back in around 2014 and 2015. Is it cost savings, increased sales, less waste, safety, all the above? ‍ Mark Diener : Pretty much all of the above.

Extraction 52

Extraction Data Hemp Research and Development 52